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The intense debate over agricultural biotechnology is at once fascinating, confusing and disappointing. 
It is complicated by issues of ethical, moral, socio-economic, political, philosophical and scientific 
import. Its vocal champions exaggerate their claims of biotechnology as saviour of the poor and 
hungry, while, equally loudly, its opponents declare it as the doomsday devil of agriculture. 
Sandwiched between these two camps is the rest of the public, either absorbed or indifferent. 
Biotechnology issues specific to the African public must include crop and animal productivity, food 
security, alleviation of poverty and gender equity, and must exclude political considerations. Food and 
its availability are basic human rights issues—for people without food, everything else is insignificant. 
Although we should discuss and challenge new technologies and their products, bringing the 
agricultural biotechnology debate into food aid for Africa where millions are faced with life-or-death 
situations is irresponsible. Agricultural biotechnology promises the impoverished African a means to 
improve food security and reduce pressures on the environment, provided the perceived risks 
associated with the technology are addressed. This paper attempts to harmonize the debate, and to 
examine the potential benefits and risks that agricultural biotechnology brings to African farmers. 
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INTRODUCTION 
 
On average, about 73 million people—about three times 
Uganda’s current population—will be added to the world’s 
population every year between 2000 and 2020.That is, 
the world’s population will increase by 25% from 6000 
million in 1995 to about 7500 million by 2020. About 
97.5% of this increase is expected to occur in today’s 
developing world (Pardey and Wright, 2002), where three 
of every four people—900 million in all—live in rural 
areas and depend directly or indirectly on agriculture for 
their livelihoods.  
Agriculture is the single most important sector in the 
economies of most low-income countries, accounting for
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one-fourth to one-half of the gross domestic product 
(GDP) and the bulk of export earnings. About 75% of 
Africans depend solely on income from agriculture and 
agribusiness, which, in turn, constitutes 40% of the GDP 
of    African    nations    (Machuka,     2003).     Productive  
 
 
 
 
agriculture, with concomitant increases in incomes, is 
needed to raise food-purchasing power and to reduce 
poverty. Poor people’s links to the land are critical for 
sustainable development. The front line of any successful 
assault on poverty and environmental degradation must 
therefore have a focus on agriculture and rural 
development.  
Africa’s current population is projected to rise to 1700 
million by 2050 (Pinstrup-Andersen and Pandya-Lorch, 
1999). Demand for imported food—mostly cereals and 
legumes—will increase from 50 to 70 million tons per 
year. If the current economic situation of Africa does not 
improve, food-deficit nations are unlikely to have the 
resources to purchase such a huge volume of food on a 
commercial basis. Several countries are already regular 
recipients of food aid. Even if food aid continues, it often 
misses the rural poor. To prevent future human 
catastrophes, African countries will have to develop and 
implement strategies for increasing agricultural 
productivity. 
Agricultural productivity can be increased sustainably in 
numerous ways, such as using inorganic and organic 
fertilizers; improving disease, pest and weed control; 
practising soil and water conservation; and using 
improved plant varieties developed either traditionally or 
through biotechnology.  
Biotechnology can be defined broadly to include 
technologies ranging from microbial fermentations to 
genomics (Persley and Doyle, 1999). Farmers and 
homemakers have been using some form of 
biotechnology for as long as they have been growing 
crops, baking breads, making cheese and preparing 
alcoholic drinks. These techniques, however, are not part 
of the biotechnology debate, which is fuelled instead by 
recent developments. Modern biotechnology has 
undergone, and is undergoing, a remarkable evolution, 
with numerous key discoveries being made, many of 
which have been subject of high-profile recognitions such 
as Nobel Prizes (Table 1).  
Agricultural biotechnology encompasses a variety of 
laboratory methods. These include cell, tissue and 
embryo culture; clonal propagation of disease-free plants; 
identification of chromosome regions (quantitative trait 
loci, or QTLs) that carry important multigenic traits; gene 
identification and isolation; genetic engineering for traits 
such as pest and disease resistance, better adaptation to 
environmental stresses, greater nutritive value and 
reduced postharvest losses; and genetically engineered 
male sterility to facilitate hybrid seed production. Properly 
integrated into traditional farming systems, biotechnology 
applications could make a difference in improving food 
security in developing countries.  
For many years, plant breeders have used 
conventional plant breeding methods to genetically 
modify plants, and to help speed natural selection and 
evolution by combining genes for resistance to biotic 
(diseases and pests) and abiotic (low soil fertility, drought  
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and salinity) stress factors, crop yield, quality, seed 
colour and many other traits of agronomic importance.  
Conventional methods of genetic modification differ 
from modern recombinant DNA technology in that the 
latter is faster and more precise in introducing specific 
genes of interest, which themselves can originate 
practically from any organism. A resulting new plant with 
a gene from another organism can subsequently serve as 
a parent to cross with another related plant in a 
conventional breeding technology. Recombinant DNA 
and conventional breeding technologies can therefore go 
hand in hand to solve some of the world’s crop 
production constraints. A major advantage of agricultural 
biotechnology is that it often generates strategies for 
genetic improvement that can be applied to many 
different crops, animals and beneficial organisms.  
Previous reviews on biotechnology in Africa have 
highlighted its status (Johanson and Ives, 2001); 
constraints to consider when implementing strategies 
(Brink et al., 1998); examples of initial applications and 
potential for development (Ndiritu, 1999; Woodward et 
al., 1999); and important issues for African policy makers 
to consider when developing an agricultural 
biotechnology strategy for the continent (Ives and 
Wambugu, 2001). This review attempts to harmonize the 
agricultural biotechnology debate and to examine the 
potential benefits and risks that agricultural biotechnology 
brings to African farmers. 
 
 
AFRICA: LAND OF POVERTY AMID PLENTY  
 
As a continent, Africa has vast natural resources, ranging 
from precious metals and stones to plant genetic 
diversity. Over generations, Africa has contributed greatly 
to the world’s agriculture, including important crops such 
as coffee (origin Ethiopia), barley (Ethiopia), tropical 
forage grasses of the Brachiaria genus (eastern and 
central Africa), teff [Eragrostis tef (Zucc.) Trotter] 
(Ethiopia) and Madagascar periwinkle (Catharanthus 
roseus (L.) G. Don. Other significant contributions 
include:  
 
• Supplying unique sources of resistance to diseases 
and pests of crops of African origin. 
• The alkaloids vinblastine and vincristine, which derive 
from the Madagascar periwinkle and form the basis 
of two anticancer drugs (Velban® and Oncovin®, 
respectively). Used to treat breast cancer and 
Hodgkin’s lymphoma, these drugs earn 
pharmaceutical companies an estimated income of 
more than US$100 million a year. 
• Teff, an ancient crop that traces back to about 3359 
BC (Mengesha, 1965), not only provides more than 
two thirds of the Ethiopian diet, but recently, has also 
found its place as a health food product in USA. It 
has very high contents of iron,  calcium,  phosphorus,  
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    Table 1.  Key milestones in the development of biotechnology. 
 
Year Development Reference 
1877 Louis Pasteur and Joules F. Joubert first describe inhibition of bacterial growth Persidis, 1999  
1922 Insulin1 is first isolated  Banting and Best, 1922 
1929 Alexander Fleming2 develops the first effective antibiotic (penicillin) from the fungus 
Penicillium sp.  
McFarlane, 1984;  
Persidis, 1999  
1944 DNA is first identified as the hereditary material in cells; this discovery was later 
confirmed in 1952 
Avery et al., 1944;  
Hershey and Chase, 1952 
1953 F. H. C. Crick and J. D. Watson3 discover DNA’s double-helix structure Watson and Crick, 1953a, b 
1960 Genetic code is deciphered4 Crick et al., 1961 
1970 Discovery of DNA ligase as catalyst for the ligation of DNA fragments Sgaramella et al., 1970 
1970 Specific restriction endonucleases are discovered5 Smith and Wilcox, 1970 
1973 The first event of genetic engineering occurs: development of molecular cloning Cohen et al., 1973 
1976 First biotechnology firm is established (Genentech, USA) Genentech, Inc. 
1977 Methods of DNA sequencing are described6 Maxam and Gilbert, 1977; 
Sanger et al., 1977 
1977 Rat insulin genes are cloned Ullrich et al., 1977 
1979 cDNA, containing the entire coding of human growth hormone mRNA, is cloned Martial et al., 1979 
1980 USA Supreme Court rules that micro-organisms can be patented Chakrabarty, 1980 
1980 Agrobacterium tumefaciens is successfully used to introduce foreign DNA into 
plants 
Hernalsteens et al., 1980 
1982 First pharmaceutical substance (insulin; Eli Lilly’s Humulin®) produced by a 
genetically engineered bacterium approved for sale in USA and UK 
Eli Lilly and Company, 2003 
1982 First transgenic animal is produced (growth hormone gene transferred from a rat to 
a mouse) 
Palmiter et al., 1982 
1984 First transgenic plant is produced, using an Agrobacterium transformation system De Block et al., 1984  
1985 K. B. Mullis7, working for Cetus Corporation, California, invents the polymerase 
chain reaction (PCR)  
Saiki et al., 1985 
1985 U.S. Patent Office extends patent protection to genetically engineered plants Hibberd, 1985 
1985 First transgenic farm animals are produced (pig, rabbit and sheep) Hammer et al., 1985 
1988 U.S. Patent Office extends patent protection to genetically engineered animals Leder and Stewart, 1988 
1988 Thermal stable DNA polymerases are isolated from thermophylic bacteria, making 
PCR a very useful procedure 
Innis et al., 1988 
1988 Human genome mapping project starts NRC, 1988 
1990-
1992 
First transgenic wheat and maize plants are produced, extending genetic 
engineering to cereals 
Gordon-Kamm et al., 1990; 
Vasil, 1999; Vasil et al., 1992 
1993 First gene for plant disease resistance (Pto) is cloned Martin et al., 1993 
1994 Genetically modified tomato is marketed in USA Kramer and Redenbaugh, 1994 
1996/97 A cloned sheep named Dolly is born at the Roslin Institute, Scotland  Campbell et al., 1996; 
Wilmut et al., 1997 
2002 Draft sequences of the rice genome are published  Goff et al., 2002; Yu et al., 2002 
2001 National Center for Food and Agricultural Policy quantifies, for U.S. farmers, the 
benefits of crop biotechnology in 30 crops 
Gianessi and Silvers, 2001 
2002 About 59 million hectares of land are planted to genetically modified crops James, 2002 
2003 The famous cloned sheep Dolly is put to sleep in February 2003, after being 
diagnosed with a progressive lung disease 
Giles and Knight, 2003 
The following Nobel Prizes were awarded in connection with advances in biotechnology: 
11923, Physiology or Medicine, to F. G. Banting and J. J. R. Macleod (both of the University of Toronto, Canada) for the discovery of insulin. 
21945, Physiology or Medicine, to A. Fleming (University of London, UK), and E. B. Chain and H. W. Florey (both of Oxford University, UK) for their 
discovery of penicillin and its capacity to cure various infectious diseases. 
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31962, Physiology or Medicine, to F. H. C. Crick (Institute of Molecular Biology, Cambridge, UK), J. D. Watson (Harvard University, Cambridge, MA), 
and M. H. F. Wilkins (University of London, UK) for their discoveries in the molecular structure of nucleic acids and its significance for information 
transfer in living organisms. 
41968, Physiology or Medicine, to R. W. Holley (Cornell University, Ithaca, NY), H. G. Khorana (University of Wisconsin, Madison, WI), and M. W. 
Nirenberg (National Institute of Health, Bethesda, MD) for their interpretation of the genetic code and its role in protein synthesis. 
51978, Physiology or Medicine, to H. O. Smith and D. Nathans (both of the School of Medicine at the Johns Hopkins University, Baltimore, MD), and 
W. Arber (Biozentrum der Universität Basel, Switzerland) for their discovery of restriction enzymes and their application to molecular genetics. 
61980, Chemistry, to P. Berg (Stanford University, Stanford, CA) for his work on the biochemistry of nucleic acids and recombinant DNA; and to W. 
Gilbert (Biological Laboratories, Cambridge, MA) and F. Sanger (MRC Laboratory of Molecular Biology, Cambridge, UK) for their work on nucleic acid 
sequencing. The 1958 Nobel Prize in Chemistry had also been awarded to F. Sanger for his work on protein structure, specifically that of insulin.  
71993, Chemistry, to K. B. Mullis (La Jolla, CA) for his invention of the polymerase chain reaction; and to M. Smith (University of British Columbia, 
Vancouver, Canada) for his contributions to the understanding of oligonucleotide-based, site-directed mutagenesis. 
 
 
 
copper, aluminium, barium and thiamine (Mamo and 
Parsons, 1987; Mengesha, 1965).  
 
African and European scientists are exploring Africa’s 
genetic diversity in a project to document and compile a 
database of about 7000 useful plants in Africa (Sanides, 
2002). 
Despite natural genetic wealth, many parts of Africa are 
crippled by poverty and chronic food shortages 
exacerbated by natural and man-made disasters. About 
70% of the continent’s population lives in rural areas and 
depends largely on agriculture (UNECA, 2002). Most are 
small farmers with few or no resources and using very 
few agricultural inputs if any. Many grow low-yielding 
landrace varieties on nutrient depleted soils. Diseases, 
pests and weeds cause heavy yield losses. As a result, 
crop and livestock yields are far lower than they could be. 
For example, average cereal yields in Africa are half of 
those in the rest of the developing world (FAO 2001b; 
Ongaro, 1999), indicating the potential for improvement 
using existing conventional methods like plant breeding, 
soil-fertility management, and disease, pest, weed and 
other constraint management. Deforestation for 
agricultural expansion, firewood and building materials 
has further contributed to environmental degradation. 
A major challenge for Africa is to feed its growing 
population. During the last two decades of the 20th 
century, the per capita food production in Africa declined 
(Machuka, 2003), because of dropping agricultural 
productivity and rapid population growth, which, in 
Kenya’s case, was almost 4%—one of the highest—
during the mid-1980s and early 1990s. Decline in 
agricultural productivity was associated with several 
biophysical and socio-economic factors, including an 
inability to replenish declining soil fertility; use of poor 
quality seeds; drought; inability to control heavy yield 
losses to pests, diseases and weeds; limited access and 
participation in local, regional and international markets; 
lack of, or ineffectual, implementation of supportive 
policies to boost agricultural production; poor 
infrastructure; and, particularly today, immense 
healthcare problems. 
HIV/AIDS is ravaging the continent, altering its 
demography, reducing farmer productivity, leaving 
children as orphans, and overwhelming the already 
desperate healthcare systems. According to the World 
Health Organization, Africa suffers the world’s highest 
rates of death from HIV/AIDS (81%), malaria (90%), and 
tuberculosis (about 23%) (WHO, 2001). Considering that 
about 70% of Africans depend on agriculture for their 
livelihoods, such death rates have a direct and negative 
impact on agriculture and food security.  
The Food and Agriculture Organization of the United 
Nations (FAO) grimly projects that, by 2020, the 
agricultural labour force will have dropped anywhere 
between 12% and 26% in the 10 most-affected African 
nations: Botswana, Central African Republic, Kenya, 
Malawi, Mozambique, Namibia, Republic of South Africa, 
Tanzania, Uganda and Zimbabwe (FAO, 2001a). Vital 
indigenous knowledge on agriculture may also be 
evaporating as the rates of premature deaths increase 
with the continent’s several epidemics. The loss of labour 
not only directly affects agricultural production and food 
security, but it also alters cropping systems as farmers 
switch to alternative crops that demand less labour. 
 
 
THE AGRICULTURAL BIOTECHNOLOGY DEBATE: 
ISSUES AND THEIR IMPLICATIONS FOR AFRICA  
 
Inconsistencies 
 
The potential role of agricultural and medical 
biotechnology in improving the livelihoods of the poor as 
well as the rich has been and is being debated 
vigorously. A burgeoning gap exists between the fast-
advancing modern tools of biotechnology and the general 
public’s understanding of these tools and the processes 
involving them. Unfortunately, both opponents and 
proponents of biotechnology have made the debate seem 
either black and white, missing the whole range of 
colours in between. The public debate, as reported by the 
press, is usually presented by highly vocal extremists 
with passionate views. Labels such as ‘Frankenstein 
food’ (referring to genetically modified crops) have been 
coined to scare the public. Others have dismissed 
probable disadvantages, expressing exaggerated and 
overly optimistic views of the potential of agricultural 
biotechnology to the point of insisting that biotechnology 
holds the  key  to  eradicating  hunger.  But  it  is  not  that  
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simple. We must steer a responsible path between the 
two extremes, examining the prospective benefits of 
agricultural biotechnology while recognizing its latent 
pitfalls. For African farmers, we must somehow 
harmonize the biotechnology debate and see how 
agricultural biotechnology can maximize potential 
benefits for them.  
The current agricultural biotechnology debate is 
skewed towards concerns that do not necessarily include 
alleviation of hunger and poverty and increasing 
productivity—the major and daily concerns of African 
nations.  We do not wish to imply that environmental, 
moral or ethical concerns are not of interest to Africans, 
nor suggest that agricultural biotechnology will, single-
handedly, solve Africa’s problems by making Africans 
self-sufficient in food. Instead, we need to recognize that, 
because they depend heavily on agriculture, many 
African countries stand to benefit from technologies that 
can increase crop productivity, enhance nutritional 
quality, improve soil fertility and minimize forest 
destruction. The United Nations Economic Commission 
for Africa (UNECA) concludes that agricultural 
biotechnology should be but one part of a comprehensive 
and sustainable strategy to solve Africa’s poverty 
problems (UNECA, 2002).  
Regarding agricultural biotechnology, Europe has 
perhaps the most concerned public. The fourth 
Eurobarometer Survey revealed interesting insights into 
the public’s psyche. For example, it differentiates 
between different applications of biotechnology and does 
not summarily dismiss biotechnology as a whole. That is, 
while it opposes genetically modified (GM) foods, the 
public strongly supports biotechnology applications for 
medicine and the environment (Gaskell et al., 2000). With 
GM crops, Europeans are more concerned about 
perceived food safety rather than potential environmental 
impacts. In general, for biotechnologies with perceived 
high benefits, these benefits overrule the perceived risks 
associated with them, whereas those perceived as 
having few or modest benefits receive no support, even if 
they have few or no risks. In other words, the public is 
willing to take risks if they perceive substantial benefits. 
The European public has no shortage of food and, 
understandably, sees no reason for modifying the current 
method of food production in a way that suggests 
‘meddling with nature’.   
In November 2002, Europe introduced a law to label as 
‘genetically modified’ food that has more than 0.9% of 
detectable GM ingredients. In addition, ‘accidental 
contamination’ of up to 0.5% is permitted without 
labelling, even for GM ingredients that have not yet been 
approved in Europe. GM crops for animal feed and 
animal feed containing GM-derived ingredients are 
required to be labelled as such, but meat and dairy 
products from animals feeding on GM crops do not have 
to be labelled. The debate over this law has already 
started,  and  the  European  Parliament  is  expected   to  
 
 
 
 
approve the law during 2003.  
Genetically modified organisms (GMOs) that have 
elicited little or no controversy include those used 
worldwide in healthcare products (e.g. insulin, hepatitis 
vaccine, medication for cardiovascular diseases and 
gene therapy) and industry (e.g. bioremediation, food 
additives and food processing). For example, the cloning 
and expression of sequences encoding the human 
growth hormone is considered a medical breakthrough. 
The hormone was initially available as minute extractions 
from human cadavers. The production of the hormone, 
using recombinant DNA technology, is an excellent 
example for which no other preferred or equivalent 
source exists and, thus, no controversy on the 
methodology used to produce the product. The same 
applies to various vaccines. Perhaps the general public 
has no sympathy or appetite for debates involving 
healthcare products?  
In Africa, chronic food shortages, famines and 
malnutrition determine choices between life and death. 
Are these issues not as important as pharmaceutical 
drugs? Food is a basic need, and access to food is a 
basic human rights issue. If one does not have food, 
everything else becomes insignificant, as a Chinese 
proverb vividly puts it: ‘A person who has food has many 
problems; a person who has no food has only one’. 
Discussing and debating environmental or ethical issues 
is hard with destitute people who have lost their dignity 
and their hope for life because they have nothing to eat. If 
we want to address biotechnology issues relevant to 
Africa, we must include crop and animal productivity, food 
security, alleviation of poverty and gender equity, and 
exclude political considerations. While we should debate 
and challenge new technologies and their products, 
bringing the GMO debate into food aid in Africa when 
millions are faced with life-and-death situations is 
irresponsible. When people are reduced to eating grass, 
is it ethical to prevent them from consuming GM foods 
that are nevertheless being consumed by millions of 
people around the world? Who really would prefer to die 
rather than eat GM foods?   
It is misleading to merge all GM crops together and 
discuss their potential benefits and perceived risks as if 
they were all one and the same. Discussion should be on 
a case-by-case basis, according to the origin of the 
introduced foreign gene, the sought-after benefit, the 
nature of the particular crop, the region and location of 
GM deployment and the perceived risks.  Genes cloned 
and introduced into plants are various, including: 
 
• Genes from plant viruses to enhance virus resistance 
(Baulcombe, 1996). 
• Bacterial toxin genes for insect resistance (Schnepf 
et al., 1998). 
• Bacterial genes for herbicide resistance (De Block et 
al., 1989; Padgette et al., 1995). 
• Bacterial genes for abiotic stress  tolerance  (Garg  et  
 
 
 
 
al., 2002). 
• Plant genes for improving either resistance to biotic 
stresses (Martin et al., 2003) or crop quality (Ye et 
al., 2000). 
• Direct modifications of a plant’s own genes such as in 
the modified Flavr Savr® tomato (Kramer and 
Redenbaugh, 1994). 
• Genes from humans or animals for 
biopharmaceuticals (Giddings et al., 2000). 
 
Each of these genes has different potential risks and 
benefits and should be analysed as such. For example, 
Hawaiian crops of papaya, a tropical fruit rich in vitamins 
A and C, were being wiped out by the devastating viral 
disease, papaya ringspot. Transgenic papaya was the 
only effective alternative for developing resistance to 
ringspot. A group of researchers from Cornell University, 
University of Hawaii and others (Gonsalves, 1998; 
Gonsalves et al., 1998) introduced the virus’s coat protein 
gene into commercial papaya cultivars, creating GM 
papayas that were highly resistant to the virus. These 
new resistant papayas are believed to have saved an 
estimated US$47 million for the Hawaiian papaya 
industry.  
The potential of GM plants is vast, once the genome 
sequences of various plants are available and the 
functions understood. Modifying and controlling 
expressions of several traits of interest would be within 
easy reach without introducing controversial foreign 
genes. Current examples include delayed fruit ripening 
(e.g. tomatoes), altered plant height, controlled flowering 
time and gene expression in specific tissues. We envision 
a future when cloned genes for various important 
agronomic traits can be purchased—just like a bag of 
fertilizer or package of pesticide—and introduced into a 
plant of interest with the user knowing little or nothing of 
how to do so. 
The potential risks of products of modern biotechnology 
that are being debated (mainly GMOs) generally fall into 
four categories: (1) food safety issues, which include 
toxic reactions, allergies and antibiotic resistance; (2) 
environmental issues such as damage to beneficial 
insects, gene flow, creation of super weeds, creation of 
new viruses; (3) socio-economic issues (‘Terminator’ 
gene technology; high concentration of biotechnology 
research and development in developed countries 
widening the income disparity between developed and 
developing countries, and small and large farmers); and 
(4) ethical and religious issues.  
 
 
Food safety issues 
 
Food safety is an important issue to be addressed.  
Several toxic fungal metabolites associated with some of 
our foods have been known for centuries (Cardwell et al., 
2001), long before the  appearance  of  GM  crops.  Well- 
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known toxins include aflatoxin, fumonisins and ergot 
alkaloids, and some are even carcinogenic, as is aflatoxin 
(Hall and Wild, 1994). The cost of regulating aflatoxin is 
high for African countries exporting peanuts. Catastrophic 
effects of ergot alkaloids on human health were observed 
in some parts of Ethiopia in the 1970s (A. Mengistu, April, 
2003, personal communication). Thus, food safety issues 
are concerns that apply to all our food products, 
irrespective of the methods applied to produce them. 
Neither are they unique to GM products. 
The highly publicized food safety scare of the ‘mad cow 
disease’ (nothing to do with GM foods) in Europe, and 
other food safety concerns, has made—unsurprisingly 
so—the public sensitive to GM food issues. Even though 
the case of the ‘mad cow disease’ has little to do with 
modern agricultural biotechnology, it is worth looking at 
because of its impact on the public’s perception of food 
safety and its ultimate mistrust. 
A physician, C. Gajdusek (of the National Institute of 
Health, Bethesda, MD) was awarded the 1976 Nobel 
Prize in Physiology or Medicine for his work in the 1950s 
to determine the infectious nature of an unusual disease 
among the females of a New Guinean tribe. Affected 
females developed unsteadiness and shaking of the 
limbs and eventually died of neurological deterioration. 
He hypothesized that the condition was associated with 
the traditional custom of females eating the brains of 
dead people. Subsequent experiments with 
chimpanzees, using extracts from brains of people who 
died from the disease revealed the infectious nature of 
the condition. Cannibalism was then banned in 1959.  
A similar disorder in sheep called ‘scrapie’ (affected 
sheep tend to scrape themselves against fences and 
trees, hence the name) has been known in UK since the 
18th century (Brown and Fischbach, 1997).  The causal 
agent of the disease was identified as a protein 
(designated as ‘prion’, a combination of the words 
‘protein’ and ‘infection’) in the 1980s.  
In 1986, ‘mad cow disease’ broke out in UK. It soon 
became apparent that the cattle with this disorder had 
been fed meat-and-bone meal prepared from sheep 
infected with scrapie, raising the possibility that the prion 
had probably jumped the species barrier between sheep 
and cattle. Moreover, meat-and-bone meal supplements 
had also been prepared from cattle and fed to cattle—a 
direct parallel to the old cannibalism practiced by the New 
Guinean tribe.  
Although the number of people afflicted with the human 
form of the disease from eating infected beef is very 
small, it was enough to cause a public food safety scare 
and create concern to the extent of setting up trade 
barriers to British beef and cattle. This case teaches us 
that human actions can have unforeseen consequences, 
no matter how benign they may seem at first.   
In the debates on the relationship between GM crops 
and food safety, allergies, toxicity and antibiotic 
resistance are among the concerns raised. In 2000-2001,  
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the United States Environmental Protection Agency 
approved for use in animal feed a GM maize known as 
‘StarLink’. The Agency had rejected it for human 
consumption because it had been modified to contain an 
insecticidal protein (Cry 9c) with characteristics that could 
potentially trigger allergic reactions. Yet, this GM maize 
found its way into food products in the USA. Claims that 
‘StarLink’ caused allergic reactions in some people 
resulted in many product recalls and raised questions 
about the value of government regulation of GM 
products. It also caused disruptions to trade between 
USA and other countries.  
Rigorous testing of GM crops can identify potential food 
safety risks before they are released for consumption 
(Taylor, 2002). For example, a project was halted after 
tests showed that some people, allergic to Brazilian nuts, 
developed allergies to a GM soybean containing a gene 
from the nuts (Nordlee et al., 1996).  
Another poker inflaming the fiery GM food safety 
debate was a paper published by Ewen and Pusztai 
(1999) in The Lancet, which examined the effects of GM 
potatoes on the digestive tracts of rats. The potatoes 
expressed a snowdrop (Galanthus nivalis L.) lectin 
(agglutinin), which is known to be toxic to mammals. The 
study claimed to have found appreciable differences 
between the intestines of rats fed with GM potatoes and 
those fed with unmodified potatoes. Not only was the 
goal of the experiment inappropriate (introducing a gene 
coding for a known poison) but the methodology 
employed and data interpretation were also doubtful 
(Mowat, 1999). Unfortunately, this work continues to be 
cited to support health hazard claims by opponents of the 
GM crop technology.   
Antibiotic resistance genes are frequently used as 
selection markers along with the specific genes of 
interest. There are concerns that antibiotic resistance 
genes may be transferred to other plants or humans, with 
the result that pathogens and pests, through constant 
exposure to their hosts, may become resistant to 
antibiotics and thus become much more intractable 
problems. However, antibiotics resistance genes confer 
no selective advantage to plants, making this issue of 
gene flow fairly academic. Since only peptides are 
absorbed, there is no threat of humans developing 
antibiotic resistance. Even so, this issue is being 
addressed because other markers are being developed 
and used (Goddijn et al., 1993; Haldrup et al., 1998; 
Kunkel et al., 1999). Methods are also available to 
remove antibiotic resistance marker genes before the 
modified crop is commercialized (Zubko et al., 2000). 
Also being developed are tissue-specific promoters, 
which cause transgenic genes to be expressed in a 
limited set of plant tissues. These types of improvements 
are reducing some of the potential problems associated 
with transgenic plants.   
Current data show that transgenic crops can enhance 
food safety.  For example, GM  maize  containing  Bt  has  
 
 
 
 
reduced predisposition to infections by mycotoxin-
producing fungi such as Aspergillus and Fusarium spp.  
Mycotoxin levels in maize food products are therefore 
reduced (Munkvold et al., 1999; Windham et al., 1999). 
Likewise, transgene-induced gene silencing has been 
used to prevent allergens accumulating in crops (Herman 
et al., 2003). These positive findings imply that the 
potential benefits of transgenic crops in enhancing food 
safety should also be taken into account when 
considering potential risks.  
The genetic modification of plants into “factories” for 
producing pharmaceutical substances (Epicyte 
Pharmaceutical, nd; Giddings et al., 2000) is 
controversial for fear of contaminating food supplies. The 
idea of producing vaccines, especially heat-stable 
vaccines, in edible fruits and vegetables is appealing 
because they would save many lives among the poor 
communities of the developing world.  Vaccines against 
infectious diseases have been produced in potatoes and 
bananas (Thanavala et al., 1995). Edible HIV vaccine, 
containing the protein HIV gp 120, was produced in 
maize that was genetically modified to contain a key 
protein found on the surface of the monkey form of HIV. 
This edible vaccine was developed by ProdiGene 
Company (USA; New Scientist, 2002) and was tested in 
an HIV vaccine trial in Thailand in 2002. In applying such 
vaccines, we have to ask two questions: whether this 
would endanger our food sources; and whether 
introductions of genes from one animal species to 
another would weaken species barriers, enabling certain 
diseases to jump species, and thus endangering targeted 
populations.  
Finally, much of the soybean and maize produced in 
USA consists of transgenic varieties, and people have 
been consuming GM food products for some time now. 
So far, no cases of ill health from such consumption are 
known, bringing us to the question of why Africans cannot 
safely grow and consume crops genetically modified with 
enhanced agronomic traits of importance. 
 
 
Environmental issues 
 
Modern crop production negatively affects the 
environment overall through use of pesticides, fertilizers 
and herbicides, tillage practices and other human 
interventions in natural systems. To examine and 
understand environmental issues, we need to look back 
at historic cases. A good example is the pesticide 
dichloro-diphenyl-trichloroethane (DDT), discovered by P. 
H. Müller, in the laboratories of J. R. Geigy Dye-Factory 
Co., Basel, Switzerland, in 1939. Müller received the 
1948 Nobel Prize in Physiology or Medicine for his work. 
DDT was seen as a miracle pesticide and used for 
various agricultural and non-agricultural (e.g. delousing 
humans and controlling mosquitoes) applications. It was 
cheap and easy to apply, and had a very broad  spectrum  
 
 
 
 
of activity. It became a ‘darling’ worldwide, increasing 
yields of treated crops and reducing malaria by 
controlling vector mosquitoes.  
However, in 1962, Rachel Carson eloquently and 
meticulously outlined the hazards of DDT in a book 
entitled Silent Spring (Carson, 1962). Her book helped 
create public awareness by highlighting the vulnerability 
of nature to human technological interventions. It became 
the foundation of the environmental movement. In 1972, 
a U.S. federal ban was placed on DDT. It was 
subsequently banned in Europe and other parts of the 
world, but is still being used in several developing 
countries, including many in Africa, mostly to combat 
malaria-transmitting mosquitoes. Because the 
consequences of malaria are more devastating than 
those of DDT, developing nations must choose the less 
dangerous of the two risks.  
This case and others have perhaps created suspicions 
in the mind of the public against chemical companies and 
a mistrust of governments. Environmental groups have 
not forgotten that some agrochemical companies 
campaigned to discredit Silent Spring.  Now, some of the 
same big companies are promoting commercial GM 
crops. Results of the Eurobarometer Survey suggest that 
the European public thinks that their governments are 
united with companies to promote biotechnology (Gaskell 
et al., 2000). For information on biotechnology, more 
opponents   than   supporters    of    biotechnology    trust 
environmental organizations rather than other sources. 
Surprisingly, despite their strong opinions, about 80% of 
both supporters and opponents admit they are 
‘insufficiently informed about biotechnology’ (Gaskell et 
al., 2000). 
In 2002, almost all of the 58.7 million hectares of 
commercial GM crops grown possessed genes for 
herbicide resistance and/or insect resistance (James, 
2002). Bacillus thuringiensis was first discovered in 
Germany in 1911 where its fatal effects on larvae of the 
flour moth were detected (Heimpel and Angus, 1960). 
Since then, organic farmers have used this bacterium as 
a biocontrol measure, and compounds containing spores 
of the bacterium are available on the market. The 
bacterium produces Bt toxin that affects the digestive 
tracts of certain insects. Through modern technologies, 
the bacterial gene encoding the toxin was transferred to 
plants. GM crops containing the Bt gene produce the 
insecticidal protein, thus, making them resistant to insect 
pests. 
Biocontrol was one strategy that Rachel Carson had 
advocated. She did not advocate a complete ban on 
pesticides, but urged caution on using pesticides on a 
widespread basis, advocating an integrated approach, 
with a minimum of chemicals, together with biological and 
cultural management strategies of pests and diseases. 
Had she been alive today, it would have been interesting 
to see whether she would have supported or opposed the 
use of biotechnology tools to control diseases and pests.  
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The herbicide Roundup® (active ingredient glyphosate) 
was introduced in 1974. It disrupts a plant enzyme called 
EPSP (5-enol-pyruvylshikimate-3-phosphate) synthase 
(Steinrucken and Amrhein, 1980), which is essential for 
producing certain amino acids required for plant growth. 
Herbicide-resistant plants possess an EPSP synthase 
that resists disruption by glyphosate. The main issues 
surrounding these GM crops are: 
 
• The possibilities of having adverse effects on non-
targeted insects (Losey et al., 1999; Poppy, 2000) 
• Bt accumulation in the soil from root exudates of Bt 
crops and its potential effect on soil biota (Saxena et 
al., 1999) 
• Unwanted pollen transmissions to nearby non-GM 
crops and wild relatives (Ellstrand et al., 1999) 
• Possible creation of new and ‘super’ weeds (Tiedje et 
al., 1989) 
 
However, these concerns can apply to any improved 
crop variety with specific traits of interest, regardless of 
how the variety was developed. In addition, studies by 
Strickland (1999) showed that, under field conditions, 
unwanted Bt maize pollen rarely reaches the levels toxic 
to the larvae of the non-targeted monarch butterfly, in 
contrast to the findings of Losey et al. (1999), who 
conducted laboratory experiments.  
The use of pathogen-derived resistance to control plant 
viruses is of concern to those who envisage a possible 
creation of new viruses with new host ranges and higher 
virulence. The potential benefit of virus-resistant 
transgenic crops is enormous and, thus, risk assessment 
of virus-resistant transgenics becomes equally important. 
Although virus recombination and gene transfer do occur 
naturally and are not unique to GM crops (Aaziz and 
Tepfer, 1999), the extent of their happening in virus-
resistant transgenic plants, compared with non-
transgenic ones, must be studied extensively (Tepfer, 
2002). 
Strategies to address concerns of unwanted pollen 
dispersion from GM crops include using tissue-specific 
promoters and introducing genes into plant chloroplast 
instead of nuclear DNA. The latter strategy would prevent 
transgenes spreading via pollen in those species where 
chloroplasts are strictly maternally inherited (Daniell et 
al., 1998; DeGray et al., 2001; Lutz et al., 2001; Scott and 
Wilkinson, 1999). The use of male-sterility tools can also 
minimize gene flow via unwanted pollen. As technologies 
advance, more techniques may become available to 
make the pollen transmission of introduced genes 
ineffective.  
 
 
Socio-economic issues 
 
With the advent of modern biotechnology, the private 
sector has become a major player in research. The  main 
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reason is that the possibility of obtaining and enforcing 
intellectual property rights (IPR) on biotechnology 
products and processes can make these investments 
potentially profitable. The dominance of the private 
sector, especially multinationals, has provoked strong 
response from some sectors of civil society.  Their 
concerns are that by patenting IP, the private sector 
could potentially hamper public-sector research by 
limiting access to IP. This is particularly worrying because 
the playing field is not perceived to be even between the 
public and private sectors with regard to knowledge and 
capacity to deal with IPR issues.  
Moreover, the private sector research agenda is usually 
different from the public one (e.g. ‘Terminator’ gene 
technology) with the result that biotechnologies may 
negatively affect poor farmers and further widen gaps 
between the rich and the poor. One case is that of 
genetic use restriction technology (GURT), also known as 
the Technology Protection System (TPS) or, more 
usually, the ‘Terminator’ technology. In March 1998, the 
U.S. Department of Agriculture (USDA) and the Delta and 
Pine Land Company (D&PL) were awarded a patent (filed 
June 1995) of genetic modifications that prevented seeds 
from germinating in the second generation (Oliver et al., 
1998). In simple terms, on applying this patented work, a 
gene encoding a protein that enables plants to 
specifically kill their own seeds comes into action. 
Effectively, farmers are prevented from replanting in the 
following season, and anyone wanting to use any of the 
genes in a breeding programme will have little or no 
access to the genes. Whether one opposes the 
technology or not, it is, undoubtedly, creative genetic 
engineering at work. 
This attempt—the ‘Terminator’ gene technology—
aimed mostly to enforce patent regulations, that is, to 
protect IP rights. Eventually, it resulted in a public 
relations disaster for the organizations and agrochemical 
corporations involved. The technology of controlling seed 
germination does not benefit either farmers or 
consumers, being a strict biological policing strategy to 
force farmers to purchase seeds annually, and thus 
enhance corporate profits. Moreover, such a technology 
could harm farmers. In Africa and other parts of the 
world, farmers traditionally save seed from one season to 
plant the next. If farmers were unaware that the seeds 
from the GM crops would not germinate—indeed, if they 
were unaware that they were planting a GM crop—the 
resulting crop losses could have serious consequences. 
The potential social and economic consequences of this 
technology have been extensively discussed in articles 
and press releases by the Rural Advancement 
Foundation International (RAFI; now ETC group, an 
action group on erosion, technology and concentration, 
Winnipeg, Canada) (ETC group, nd).  
 
 
 
 
 
 
Ethical and religious issues 
 
The ethical and religious concerns arise from the belief 
that scientists are playing God and that the modern 
recombinant DNA technologies allow them to encroach 
extensively into natural processes in unnatural ways. 
However, one can also question whether it is ethical to 
dismiss technologies that may otherwise provide 
solutions to human and animal suffering, whether from 
famine or poor health. In addition, cloning is not 
completely unnatural. Some organisms (e.g. bacteria, 
yeasts, shrimps, plants with apomictic reproduction such 
as Brachiaria species and some snails) naturally 
reproduce by cloning themselves. Gene transfer between 
bacteria and plants is not unnatural either. The plant 
genetic engineering revolution started with understanding 
the natural mechanisms in which the soil-borne pathogen 
Agrobacterium tumefaciens causes crown gall disease in 
plants. Strains of the tumour-causing pathogen contain a 
TI plasmid. During infection, part of this plasmid transfers 
naturally into the plant genome, resulting in the tumour 
phenotype. A similar process also exists naturally 
between A. rubi and A. rhizogenes and plants.  
When opposition to GMOs or other biotechnology 
applications is based on ethical or religious beliefs, 
scientific evidence is irrelevant. This attitude is basically 
the same as that of excluding certain foods from the diet 
because of religious beliefs.  No one suggests that any 
person or group be obliged to accept agro-
biotechnologies.  
 
 
CHALLENGES AND OPPORTUNITIES IN 
AGRICULTURAL RESEARCH AND POLICY 
 
To make an impact in Africa, biotechnology research 
must be pro-resource-poor farmers and pro-women and 
children, target crops that African farmers traditionally 
know how to grow and address agronomic traits of 
significant importance to their needs.  
The currently available and widely commercialized GM 
traits are not good examples of technologies that will help 
resource-poor farmers. Most small African farmers 
cannot afford herbicides or pay high premiums for 
purchasing GM seeds. Available GM crops are not 
designed for poor African farmers and it is doubtful that 
large agricultural companies will ever design crops 
exclusively for the benefit of poor African farmers. African 
scientists, international agricultural research centres 
(IARCs) and other players need to join forces to tackle 
the specific problems that African farmers face. For 
specific major agricultural constraints where no 
conventional methods are currently available to solve 
them, Africans, instead of shying away, should turn to 
agricultural biotechnology as another potential source of 
solutions.  
 
 
 
 
 
Several agricultural biotechnology initiatives are 
tackling constraints of importance to Africa. UNECA 
(2002) reports on ongoing plant biotechnology activities 
in several African countries; and Walter S. Alhassan 
(2003) describes those for West and Central Africa. 
 
 
Research 
 
Enhancing crop yield 
 
The ‘Green Revolution’ largely by-passed Africa, even as 
it changed chronically food-deficit countries in the 
developing world to becoming self-sufficient to the extent 
that some now produce surpluses for export (e.g. India, 
Thailand and Vietnam as rice exporters). The second, 
biotechnology inspired, revolution promises further 
advances in humankind’s ability to feed its growing 
population, expected to reach between 8000 and 10,000 
million in 2030 (Welch and Graham, 2000). The question 
among policy makers and their development partners is 
whether Africa can afford to be by-passed again, this time 
by the second revolution. 
Genes for dwarfing. The Norin 10 genes responsible for 
height reduction (gibberellin-insensitive-dwarfing genes) 
in the Green Revolution have been cloned and 
introduced into other crops (Peng et al., 1999). These 
genes enabled plants to be shorter, stronger and more 
responsive to fertilizers without lodging. In addition, 
plants with these genes invest more in reproductive plant 
parts, which are consumed, instead of vegetative parts, 
thus enhancing yield. These genes can be useful in 
certain African crops if deployed strategically to enhance 
food production. 
 
 
Improving crop adaptation to biotic and abiotic stress 
factors 
 
Biotic stresses. Diseases, pests and weeds are major 
constraints encountered by African farmers, most of 
whom lack the resources to chemically control them. 
Hand weeding, a backbreaking task, is often done by 
women and children, and consumes a large part of their 
time. All disease, pest and weed management methods 
and strategies have associated economic and/or 
environmental costs. Pathogens, pests and weeds for 
which no suitable control strategies exist are good 
candidates for new biotechnology approaches. 
Plant genetic engineering can enhance traits to resist 
attacks by pathogens or insect pests (Bent and Yu, 1999; 
Fermin-Muñoz et al., 2000). Advances have been made 
in understanding the mechanisms involved in host-
pathogen interactions (Keen, 2000; Michelmore, 1995). 
Specific resistance genes of plant origins continue to be 
cloned and introduced into crops to enable them to 
defend themselves from pathogens (Hammond et al., 
1998; Tang et al., 1999; Witham et al., 1996).  More  than  
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30 genes have been isolated from various plants to 
provide resistance to a wide range of pathogens and 
pests (Hulbert et al., 2001).   
Other strategies have also been used to enhance plant 
resistance with genes from plants (Broekaert et al., 1997; 
Broglie et al., 1991; Cao et al., 1998; Chamnongpol et al., 
1998; Oh et al., 1999). Some innovative methods of 
fighting plant pathogens include:  
 
• Pathogen-derived resistance to combat plant viral 
diseases (Cooper et al., 1995; Palukaitis and Zaitlin, 
1997; Perlak et al., 1994; Powell-Abel et al., 1986; 
Smith et al., 1992; Yepes et al., 1996). 
• The use of antimicrobial proteins and lysozymes from 
insects (Jaynes et al., 1987), animals (Vunnam et al., 
1997), microbes (Lorito et al., 1998) and even 
humans (Nakajima et al., 1997). 
• The cloning and expression of antibody molecules 
linked to carrier peptides in plants to combat 
diseases (Franconi et al., 1999) and nematodes 
(Baum et al., 1996). 
 
Biotechnology tools are also important in pathogen 
population studies (Kelemu et al., 1999; McDonald and 
Linde, 2002; McDermott and McDonald, 1993) and 
diagnostics and detection (Kelemu et al., 2003; Martin et 
al., 2000; Louws et al., 1999). 
Many of the landrace varieties conserved by African 
farmers over generations have numerous desirable traits, 
including disease and pest resistance (e.g. Ethiopian 
barley landrace varieties). Although much has been 
done, additional efforts are needed to combine these 
valuable traits through conventional plant breeding. 
Fortifying conventional plant-breeding methods needs to 
be combined with efforts to improve soil fertility and other 
integrated crop management strategies that enhance 
crop productivity. When sources of resistance are 
available, the control of plant diseases and pests through 
resistant plant varieties is the most efficient and 
economically viable method. African countries should 
invest in gene discovery from their rich plant genetic 
resources and untapped microbial gene pools.  
Agricultural biotechnology offers some hope of 
controlling some major diseases for which currently 
available management strategies are not so effective. For 
example, the fungal disease black Sigatoka causes 
substantial yield losses in banana and plantain (Musa 
spp.) (Fullerton and Stover, 1990; Ploetz, 2001), the most 
important fruit crops in Africa.  Because of banana’s 
ploidy level, interbreeding to enhance resistance to 
diseases and pests is difficult, and chemical control has 
become a major component of banana production in 
export plantations like those found in Costa Rica and 
Honduras. The annual cost of fungicide applications, 
which are sprayed by aircraft, is about US$1000 per 
hectare (Ploetz, 2001). This control measure strategy is 
clearly not an option for  small  resource-poor  farmers  in  
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Africa. This is the type of problem where genetic 
engineering perhaps holds the best potential solution.  
Another major fungal disease of an economically 
important crop is black pod disease, caused by 
Phytophthora spp., which attacks cacao in West and 
Central Africa (Erwin and Ribeiro, 1996; Evans and Prior, 
1987). This region produces nearly 70% of the world’s 
cocoa beans.  
Striga is a parasitic weed of importance in Africa, 
infecting cereals such as maize, millet, sorghum, rice and 
sugar cane. Each striga plant can produce thousands of 
seeds that may remain dormant in the soil for several 
years until an appropriate host stimulates germination. 
The problem is more intense in dry and low soil-fertility 
areas. Several organizations, including Centro 
Internacional de Mejoramiento de Maiz y Trigo 
(CIMMYT), International Institute of Tropical Agriculture 
(IITA), the International Centre of Insect Physiology and 
Ecology (ICIPE), several African national research 
organizations and universities are currently working on 
various strategies to combat this parasitic plant. Perhaps 
the most effective approach would be a concerted effort 
by some of these organizations and others to design 
control strategies, including well-thought-out 
biotechnology approaches similar to those proposed by 
Kanampiu et al. (2002). 
While recognizing the potential, we need to remember 
that planting GM crops alone is not equivalent to waving 
a magic wand to solve all agricultural problems. Like the 
crop varieties created through conventional breeding 
strategies, they must be combined with other 
conventional approaches such as good soil-fertility 
management and other optimal conditions for crop 
production. Insect- or disease-resistant GM crops, like 
those developed through conventional breeding methods, 
will, with time, succumb to insect or pathogen pressures. 
Insects and pathogens have various mechanisms to 
overcome resistance. However, by combining different 
forms of resistance from different sources (organisms) 
through recombinant DNA technology we may gain an 
advantage by dramatically building a fortified barrier that 
is more difficult for insects and pathogens to overcome. 
Postharvest losses. Farmers, particularly resource-poor 
farmers, who grow easily perishable but high-value crops 
such as fruits and vegetables may suffer postharvest 
losses as high as 50% (Eckert and Ogawa, 1985). Many 
African consumers have no refrigerator, leading to 
spoilage of their purchases.  In developed nations, 
postharvest losses have been reduced through the use of 
agrochemicals and improved storage technologies 
(Eckert and Ogawa, 1988). The use of postharvest 
chemicals becomes unattractive as pathogens gradually 
develop resistance to chemicals (Holmes and Eckert, 
1999) and the public’s negative perception of pesticides 
increase. Technologies that prolong shelf life and reduce 
high spoilage levels in fruits, vegetables and root crops 
would, without question, have significant impact  for  both  
 
 
 
 
African farmers and consumers. Plant genes involved in 
fruit ripening have been introduced in reverse orientation 
to create plants (e.g. Flavr Savr® tomato) with delayed 
ripening and prolonged shelf life. Work in the pipeline 
includes that of Syngenta, which is developing banana 
with prolonged shelf life and may be commercialized by 
2006 (ABE, 2003).  
Abiotic stresses.  Food shortages in Africa are strongly 
associated with environmental calamities. The major 
abiotic stress factors affecting food production in sub-
Saharan Africa are low soil fertility, drought, salinity, soil 
acidity and heat stress. They are expressed in crops 
through a series of morphological, physiological, 
biochemical and molecular changes that affect plant 
growth and productivity (Wang et al., 2001). Resistance 
to abiotic stress factors is multigenic, as well as 
quantitative in nature. Attempts with conventional 
breeding methods to develop crop varieties resistant to 
multiple abiotic stresses have been only partly 
successful. Efficient identification, isolation and use of 
favourable genes for breeding stress-resistant genotypes 
may require other efficient tools, including molecular 
markers, functional genomics and transgenic technology.   
Several different experimental systems, including lower 
and higher plants and microbes, have been analysed for 
plant abiotic stress responses (Grover et al., 2001). 
Stress response has been analysed at the molecular 
level to discover stress proteins, stress genes, stress 
promoters, trans-acting factors that bind to stress 
promoters and signal transduction components involved 
in mediating stress responses. The functional relevance 
of stress-associated genes is being tested in different 
trans-systems, including yeast and higher plants. To 
overcome the scarcity of abiotic-stress-specific 
phenotypes for conventional genetic screenings, 
molecular genetic analysis, using a stress-responsive 
promoter-driven reporter, is a potential alternative to 
genetically dissecting abiotic-stress-signalling networks in 
plants (Xiong and Zhu, 2001). 
Soil fertility depletion on smallholder farms, together 
with the concomitant problems of weeds, pests and 
diseases, is the fundamental biophysical root cause for 
declining per capita food production in sub-Saharan 
Africa (Sánchez et al., 1997). An average of 660 kg N ha-
1, 75 kg P ha-1 and 450 kg K ha-1 has been lost during the 
last 3 decades from about 200 million ha of cultivated 
land in 37 African countries, excluding the Republic of 
South Africa (Smalling et al., 1997).  This annual loss is 
equivalent to US$4000 million in fertilizer (Sánchez, 
2002). Africa is losing 4.4 million t N, 0.5 million t P and 3 
million t K every year from its cultivated land. These rates 
of nutrient depletion are several times higher than Africa’s 
(excluding Rep. of South Africa) annual fertilizer 
consumption, which is 0.8 million t N, 0.26 million t P and 
0.2 million t K (FAO, 1995). The potential of genetically 
improved crops cannot be realized when soils are 
depleted of plant nutrients.  
 
 
 
 
The traditional way to overcome nutrient depletion is to 
apply mineral fertilizers. But fertilizers in Africa cost 2 to 6 
times as much as those in Europe, North America or 
Asia. Higher prices are the result of transport costs, 
which, in turn, are a consequence of poor physical 
infrastructure and the small volumes to be distributed 
(Mwangi, 1997). A soil fertility replenishment approach 
has been promoted by the International Centre for 
Research in Agroforestry (ICRAF) and its national and 
international partners working with farmers, using 
resources naturally available in Africa. This approach 
uses different combinations of P fertilizers and organic 
inputs to replenish soil N and P nutrient stocks. 
Growing nutrient-efficient plants on soils that are low in 
plant-available nutrients represents a strategy of ‘tailoring 
the plant to fit the soil’, in contrast to the traditional 
approach of ‘tailoring the soil to fit the plant’. The 
approach of developing nutrient-efficient crops for sub-
Saharan Africa is highly significant because, of all 
agricultural innovations, farmers most readily accept new 
cultivars. New cultivars are preferred because they yield 
better, demand less fertilizer input and need minimum or 
no changes in agricultural practices. Estimates of overall 
efficiency of applied fertilizer have been reported to be 
about or less than 50% for N, less than 10% for P and 
about 40% for K (Baligar et al., 2001).  
Inter- and intra-specific variations for plant growth and 
mineral-nutrient-use efficiency are known to be under 
genetic and physiological control, and are modified by 
plant interactions with environmental variables. Breeding 
programmes need to focus on developing cultivars with 
high nutrient-use efficiency. Fertilizer-use efficiency can 
be greatly enhanced by identifying traits that improve the 
absorption, transport, use and mobilization of nutrients in 
plant cultivars. However, the relatively slow progress in 
defining the genetic, physiological and biochemical basis 
of nutrient efficiency has hampered development of 
superior nutrient-efficient cultivars through conscious 
conventional and molecular breeding efforts geared 
specifically towards that purpose (Rao and Cramer, 
2002).  
Scientists from Mexico succeeded in growing tobacco 
plants that expressed a bacterial gene that encodes the 
enzyme citric acid synthase. They found that the 
genetically engineered plants were better able to 
solubilize the insoluble phosphate present in acid and 
alkaline soils (López-Bucio et al., 2000). This work shows 
promise for genetically enhancing the use of scarce 
nutrient resources by crops. Genes for several primary 
ion pumps, cotransporters and ion channels have been 
cloned, and the characteristics of their function are being 
studied (Dunlop and Phung, 2002). While these 
advances have yet to produce cultivars that cope better 
with low-fertility soils, they provide powerful tools to 
address some important gaps in our knowledge, 
particularly the regulation of transporter genes.  
Drought  is  perhaps  the  most  limiting  factor  to   crop 
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production on a global scale, and the situation is 
expected to deteriorate in Africa. The current trends in 
land degradation, desertification and climatic variability 
have been predicted to intensify because of global 
warming. The erratic supply of rainfall across seasons, 
poor soil-water-holding capacity and poor management of 
water resources has led to drought occurring, on 
average, once every 3 years in eastern Africa for the last 
30 years, causing human and environmental disasters. 
For instance, drought has affected common bean 
production in eastern, central and southern Africa to 
cause losses of more than 395,000 t each year (Amede 
et al., 2003).  
Although challenging, drought resistance can be 
improved through conventional breeding, using existing 
genetic diversity. Newer methods, involving molecular 
markers and comprehensive gene expression profiling, 
provide opportunities for directing the continued breeding 
of genotypes that provide stable grain yield under widely 
varied environmental conditions (Bruce et al., 2002). 
Much of the genetic variation for improving drought 
tolerance has been lost during domestication, selection 
and modern breeding, leaving pleiotropic effects in the 
selected varieties for development and adaptation 
(Forster et al., 2000). Thus, searching for new gene pools 
from primitive landraces and related wild species may 
require a different strategy. Molecular markers can be 
used to facilitate the incorporation of specific 
chromosomal segments of wild species into domesticated 
crops.  
Besides conventional breeding, several gene-transfer 
approaches can improve stress tolerance in plants by 
engineering the genetic composition in terms of 
biosynthetic and metabolic pathways (Bohnert and 
Jensen, 1996; Bohnert et al., 1995).  Iuchi et al. (2000) 
isolated two novel, drought-inducible, genes by 
differential screening. One gene, VuNCED1, encodes a 
9-cis-epoxycarotenoid dioxygenase that catalyses key 
steps in abscisic acid biosynthesis and in drought-stress 
response and tolerance in cowpea.  
Drought-resistant genotypes can be engineered, using 
genes that encode enzymes to synthesize 
osmoregulants, scavenging enzymes and cell-wall 
protectants for modifying membrane composition 
(Sharma and Lavanya, 2002). For example, transgenic 
plants over-expressing one or more components of the 
ascorbate-glutathione pathway can induce elevated 
activities towards drought resistance in cotton, wheat and 
teff (Smirnoff and Colombe, 1988). Molecular tools can 
be used to elucidate control mechanisms of stress 
resistance by engineering genes, which regulate 
osmoprotection, water and ion movement, availability of 
functional and structural stress-induced proteins and free 
radical scavenging systems (Wang et al., 2001). In 
soybean, developing drought-resistant varieties was 
possible by establishing differences in mRNA levels 
between tolerant and sensitive genotypes  for  favourable  
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genes that could be induced by drought (McLean et al., 
2000). As microarray techniques are refined, plant-stress 
biologists will be able to characterize changes in gene 
expression within the whole genome in specific organs 
and tissues subjected to different levels of drought stress 
(Bray, 2002; Liu and Baird, 2003).  
Scientists around the world are working on various 
strategies to develop drought-tolerant crops. For 
example, scientists in the Republic of South Africa are 
studying the genetic basis of a plant called ‘resurrection’, 
which thrives in desert habitats. This plant can ‘hibernate’ 
during prolonged dry periods and revive when rain is 
available. Once the mechanisms are understood and the 
genes identified in this plant, they may be used to 
enhance drought tolerance in important African crops. 
Salinity is another major constraint to crop production 
and affects 85 million hectares in Africa, where the 
amount of rainfall is insufficient to substantially leach out 
salts (Pessarakli and Szabolcs, 1999). The problem is 
especially serious in dry areas where irrigation is 
practiced. Worldwide, about 33% of irrigated land is 
affected by salinity. Land for crop production is being lost 
to salinity, in countries like Sudan and Egypt, which 
depend entirely on irrigated agriculture. The complex and 
polygenic nature of salt-stress tolerance contributes 
significantly to the difficulties in breeding salt-tolerant 
crop varieties (Zhu, 2000).  
Soil salinity affects growth and productivity by inducing 
water stress, a pH effect, a direct effect of Na ions or 
these factors in combination. Because the initial effect of 
salt stress is commonly expressed as water stress, 
improving soil-water availability improves salt resistance 
in plants. Salt tolerance can be achieved by integrating 
physiological mechanisms that help the plant prevent salt 
from entering it—either by avoidance or by high tissue 
resistance—by using alternative mechanisms. The higher 
salt tolerance of wheat and barley crop cultivars is related 
to a more effective restriction of shoot transport of both 
sodium and chloride ions (Marschner, 1995). Possibly 
efficient salt-tolerance mechanisms—other than osmotic 
adjustment—may therefore include those that help the 
plant either maintain cell-wall integrity or facilitate a 
higher uptake of K, Ca and NO3 ions.   
Researchers at Cornell University developed a GM rice 
for drought and salt tolerance (Garg et al., 2002). The 
modified rice contains bacterial genes that allow the plant 
to produce high levels of trehalose sugar, which protect it 
from not only drought but also from osmotic shock, 
enabling it to grow in saline soils. Other reports include 
salt-tolerant transgenic maize containing a gene (gutD) 
from the bacterium Escherichia coli (Liu et al., 1999), and 
salt-tolerant tomato plants that can accumulate salt in 
foliage but not in fruits (Zhang and Blumwald, 2001). 
Genes for salt tolerance have also been successfully 
transferred from a moss to a plant; and a salt-tolerance 
gene from mangroves (Avicennia marina) was cloned 
and introduced into other plants. These and other studies  
 
 
 
 
indicate that effective measures can be found to combat 
salinity stress in plants. 
Soil acidity is spreading, not only in humid and sub-
humid Africa, but also in arid parts of sub-Saharan Africa. 
It is caused mainly by occasional, high and intense 
rainfall and an improper land use that encourages 
leaching of cations that, in its turn, results in soil-nutrient 
imbalances. Soil acidity affects plant growth through low 
pH (high proton activity), aluminium (Al) toxicity, 
manganese (Mn) toxicity, nutrient imbalance and 
inhibition of root growth (Marschner, 1995). Low pH 
promotes solubilization of toxic ions such as Al and Mn, 
and can reduce the availability of certain plant nutrients 
like P, Ca, Mg, Mo and S. When the concentration of 
toxic ions increases, not only is the host plant severely 
affected but so also are symbiotic associations such as 
rhizobial multiplication, infection and nodulation (Munns, 
1986). For example, growing legumes over many 
consecutive years in the tropics will acidify the soil 
because of preferential uptake of cations (Israel and 
Jackson, 1978) and pumping of residual H+ ions by the 
plasma membrane into the rhizosphere.  
Most crop species achieve resistance to toxic levels of 
Al and Mn in soil through mechanisms that either exclude 
the elements or permit internal tolerance (Marschner, 
1995). Because growth and productivity of plants in acid 
soils require highly efficient uptake or use of nutrients like 
P, Ca and Mg, mechanisms that assist the plant to 
acquire such nutrients increase tolerance of acid soils. 
Citric acid added to soil is effective in binding Al and 
other toxic metals. Researchers in Mexico have 
genetically engineered plants to overproduce citric acid in 
roots and thus better tolerate the presence of Al in the 
soil (de la Fuente-Martínez and Herrera-Estrella, 1999; 
de la Fuente-Martínez et al., 1997). 
 
 
Enhancing the nutritional quality of African crops  
 
The World Health Organization (WHO) estimates that 
54% of child mortality in developing countries is 
associated with malnutrition. About one third of the 
children in sub-Saharan Africa suffer stunted growth 
because of poor diet. Micronutrient malnutrition is now 
recognized as being among the most serious health 
challenges facing vast sectors of Africa’s population, 
particularly resource-poor women and children (Kimani, 
2001; Smith and Macgillivray, 2000; Welch and Graham, 
2000). The major micronutrient deficiencies are in iron, 
zinc, vitamin A and iodine. These deficiencies result from 
diets that are rich in energy but poor in proteins, minerals 
and vitamins. They are further aggravated by widespread 
poverty, which makes access to the more expensive 
animal-based products such as milk, eggs and meat—all 
rich in vitamins and minerals—very difficult for the vast 
majority.  
Other aggravating factors include  a  limited  knowledge  
 
 
 
 
of the nutritional value of locally available foodstuffs, and 
changing eating habits that often regard traditional 
vegetables and other non-staples as ‘old-fashioned’. The 
preferred foods, including cereal-based products (e.g. 
sieved maize meal, wheat and milled rice), white 
potatoes and cassava, are usually low in micronutrients. 
These calorie-rich but micronutrient-poor foodstuffs are 
almost always preferred because they are readily 
available and cheap, and cook fast. Although many 
African communities keep livestock, animals are usually 
sold to generate income to meet other household needs. 
Consumption of meat products tends to be irregular, 
often only on special occasions.  
Recent data on micronutrient deficiencies in Africa 
showed that national prevalence rates of clinical vitamin 
A deficiency (VAD) in pre-school children range from as 
high as 3.45% in Ethiopia to 0.2% in Botswana and 
Cameroon (Smith and Macgillivray, 2000). Data from the 
Canadian Micronutrient Initiative (MI) from 1980 to early 
1990s also shows very high prevalence of iron deficiency 
anaemia (IDA) among children, and non-pregnant and 
pregnant women (Smith and Macgillivray, 2000).  Zinc 
deficiency was only recently recognized as a public 
health problem. Zinc is essential for normal growth, 
appetite and normal immunity function. It is an essential 
component of more than 100 enzymes involved in 
digestion, metabolism and wound healing (Guzmán-
Maldonado et al., 2002). A recent national survey in 
Kenya showed that zinc deficiency is widespread—at 
50.8% among children under five, 52.2% among mothers 
and 46.1% in adult males—and requiring urgent attention 
(Mwaniki et al., 1999). 
 
Intervention strategies: To alleviate micronutrient 
deficiency in Africa, a three-pronged approach has been 
followed: giving vulnerable groups micronutrient 
supplements, fortifying common foods and encouraging 
dietary improvement. Providing mineral supplements is 
effective where vulnerable groups are easy to reach and 
have access to medical facilities. A large capital input is 
often needed, together with an elaborate and costly 
distribution network and patience. The supplements must 
be supplied on a regular basis. This approach, however, 
leaves out those at-risk groups who are hard to reach or 
practically unreachable and other household and 
community members who are not targeted to receive 
supplements. In Africa, these groups constitute most of 
those who are located in rural communities with almost 
no access to medical facilities.  
The approach of fortifying common foods has had 
limited success in Africa because of the underdeveloped 
food industry and lack of effective legislation. At present, 
food fortification programmes are operating in Botswana 
(vitamin A in ‘Tsabana’ weaning food), Kenya (vitamin A 
and iron in wheat or maize flour, millet porridge and 
cooking oil), Malawi (vitamin A in cooking oil), Namibia 
(vitamin A and iron in maize meal), Nigeria (iron in  wheat  
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flour), Rep. of South Africa (vitamin A in maize meal and 
margarine), Uganda (iron in wheat flour), Zambia (vitamin 
A and iron in maize meal, and vitamin A in sugar) and 
Zimbabwe (vitamin A and iron in maize meal). This 
approach is effective for small affluent communities found 
mostly in urban areas and households with a capacity to 
purchase fortified foods on a regular basis. Again, it 
leaves out most of the urban poor and rural communities. 
Dietary improvement is probably the most effective and 
sustainable strategy for reducing micronutrient 
deficiencies in Africa. This approach aims to increase 
dietary availability, regular access and consumption of 
mineral-rich foods by at-risk and micronutrient-deficient 
communities. It involves developing and promoting 
enhanced consumption of culturally acceptable, mineral-
rich grains, vegetables and root crops. In 1995, the 
Consultative Group on International Agricultural 
Research (CGIAR) started a micronutrient project (Bouis 
et al., 2000) to assemble the package of tools that plant 
breeders would need to produce cultivars with increased 
levels of minerals and vitamins. Targeted crops include 
wheat, rice, maize, common bean and cassava—all 
important staples in Africa. The micronutrients being 
studied are iron, zinc and vitamin A. The project also 
seeks to determine the range of genetic variability 
available for exploitation by future breeding programmes; 
the bio-availability of the micronutrients contained in the 
grain of the best selections; the genetics, physiology and 
biochemistry of selected traits; and screening protocols 
for use in subsequent breeding programmes. 
While enhancing nutritional quality is still possible 
through conventional plant breeding, biotechnology 
opens the door to more opportunities (Wang et al., 2003). 
Examples of crops that have been modified (or are being 
modified) to include or increase health-promoting 
compounds are: 
 
• A transgenic rice with yellow seeds and exhibiting 
increased production of beta-carotene, a precursor of 
vitamin A (Ye et al., 2000). 
• Another transgenic rice with enhanced iron content, 
obtained through the expression of a soybean gene 
that helps produce an iron-binding protein (Goto et 
al., 1999). 
• Engineered tomatoes with high levels of the 
antioxidant lycopene, encoded by a gene from yeast 
(Handa and Mattoo, 2002). 
• Maize with enhanced levels of vitamin E (Rocheford 
et al., 2002). 
• Tomatoes with high levels of flavonols (strong 
antioxidants that reduce damage to body cells), 
encoded by a gene from petunia (Muir et al., 2001). 
• Sugar beet with high levels of fructan (Sévenier et al., 
1998). 
• Potatoes with enhanced lysine content (Sévenier et 
al., 2002). 
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Policy  
 
Issues stemming from a socio-economic or policy 
perspective influence how biotechnology can best 
contribute to African agricultural development. Like all 
agricultural technologies, the socio-economic impact of 
biotechnology outputs must be taken into account. 
Understanding these benefits, compared with those of 
alternatives, is crucial in deciding when and where it is 
most appropriate to invest in biotechnology. The potential 
benefits of biotechnology depend on the crop, the specific 
trait that is being improved and the gains that could be 
made from solutions other than biotechnological. The 
more important the crop, the more important the 
constraint or opportunity and the less effective the 
alternatives, the more attractive, overall, will be 
investment in biotechnology. 
Such impact, however, cannot be seen only in the 
aggregate. Like all agricultural technologies, the benefits 
of biotechnology will be distributed differentially between 
consumers and producers, and between consumers and 
producers of different wealth or income levels or different 
social groups such as small farmers, landless labourers 
and large farmers. Similarly, biotechnology will have a 
different impact on different agro-ecosystems, an impact 
that is not only socio-economic but also environmental.  
When choosing a technology to develop or deciding on 
how best to develop it, research costs need to be 
considered, together with the potential impact or benefits. 
In some cases, biotechnology may produce faster results 
more cheaply than other research methods. In other 
cases, constraints of capital or specialized, highly 
qualified, scientific personnel could make biotechnology 
more expensive or even impractical. Understanding the 
relative costs of biotechnology versus other scientific 
options is therefore an important economics issue. 
A policy issue of particular relevance in assessing the 
potential of biotechnology (e.g. to alleviate poverty) is the 
question of how intellectual property rights (IPR) can 
affect the distribution of benefits. Because much of 
biotechnology, from methods to gene constructs, is 
owned by someone, the owners of biotechnology IPR 
claim a share of the benefits. This has led to concern that 
powerful multinational corporations and other such 
entities will obtain a disproportionate share of the 
benefits. Potentially, this is a matter not only of fairness—
important in its own right—but also of reducing incentives 
for other potential beneficiaries to use the biotechnology, 
or even encouraging them to set up barriers against its 
use and thus prevent the creation of additional socio-
economic benefits. The complicated tangle that IPR 
restrictions can create may so reduce researchers’ 
‘freedom to operate’ that applying a biotechnology 
solution would not be feasible, even if it were otherwise 
attractive. The issue of IPR is of especially high concern 
to national agricultural research systems (NARS), which 
have a high demand for further research and better 
understanding of these issues. 
 
 
 
 
Biotechnology can provide a variety of tools, including 
tissue culture for improved and more rapidly available 
planting material, and molecular markers to better 
understand genetic diversity in crops and their pests. But, 
in the minds of much of the public, biotechnology is 
exclusively associated with GMOs. Because they 
introduce substantial novelty into the environment and 
food system, the public is legitimately concerned about 
how safe GMOs are. Such concerns have led to the 
design of both international and national regulatory 
systems for ensuring the safe use of GMOs. 
Implementing such systems has raised several scientific 
issues that have yet to be fully addressed. Moreover, as 
in the case of benefits, the specific scientific issues will 
vary according to the crop, its production environment, 
the trait that has been genetically modified and other 
considerations. Thus, biosafety represents an ongoing 
research agenda.  
Biosafety, however, is not just a scientific issue, but 
also a policy and socio-economic issue. Generally, 
biosafety decisions are, firstly, about risk. How much risk 
is acceptable is a value judgment or political decision 
rather than a purely scientific question. Attitudes towards 
risk are known to differ among individuals or groups, and 
this is evidenced by different national policy and 
implementation regimes to ensure biosafety. These are 
complex issues where scientific certainty does not prevail 
and choices must be made. Again, there is a strong 
demand from national systems in the developing 
countries for assistance in setting up systems that meet 
their needs for biosafety. It is worth noting that biosafety 
regulatory regimes have costs that need to be taken into 
account when investing in biotechnology.  
Likewise, consumer acceptance issues affect whether 
biotechnology innovations are in fact used. Many socio-
economic policy issues in this area also require 
considerably more research and debate. 
 
 
EFFECTIVE AND EFFICIENT PARTNERSHIPS TO 
PROMOTE EDUCATION AND ACCESS TO 
INFORMATION  
 
Capacity building 
 
The importance of capacity building in sustainable 
development cannot be over emphasized. It is reflected 
in the many initiatives that have been put forward at 
national, regional and international levels. National and 
international donor organizations, governments in 
developing and industrial countries, non-governmental 
organizations (NGOs) and the private sector are 
increasingly building policies around capacity building, 
and including them in programmes and projects. Capacity 
building has many facets that can range from training and 
development of human resources only to addressing 
instrumental issues such as developing procedures, 
management and  organizational  structures,  or  strategy  
 
 
 
 
formulation.  
Moreover, it is becoming increasingly clear that 
capacity building can contribute to sustainable 
development only if it is an integral part of a project and 
not just another extra activity. Neither is capacity building 
in biotechnology transferable; countries and 
organizations need to develop their own capacity in 
locally appropriate ways. In a biotechnology programme, 
capacity building should aim at fostering the interaction 
between producers (scientists) and end users (small 
farmers) of a technology. It becomes apparent, then, that 
capacity should be built up at all levels, from end users 
(farmers and consumers) to policy makers. Capacity 
building should be carried out to: 
 
• Increase awareness among high-level policy and 
decision makers of the interrelated areas of 
biotechnology, and food quality and safety. 
• Strengthen national capacities to identify, formulate 
and implement relevant policies. 
• Promote sound governance and standard setting. 
• Develop national and regional capacities for legal and 
regulatory frameworks. 
• Strengthen human resources in related technical and 
regulatory matters. 
• Strengthen related regional and national institutions, 
including the provision of training and scientific 
equipment. 
• Enable scientists and policy makers to fully and 
effectively participate in negotiations in international 
fora where issues related to biotechnology and 
biosafety are discussed. 
• Provide information on understanding available data, 
including for local and indigenous communities, and 
promote joint research and foster open dialogue at all 
levels, including the media (Martínez, 2001). 
 
Past experience has clearly shown that human 
resources are ultimately a key factor behind any 
progress. Two major bottlenecks for development in 
Africa comprise shortages of trained personnel and 
ineffectual means for information dissemination. 
Information, education and training allow farmers to make 
use of new farming knowledge and technologies. Both 
formal and informal training substantially affect 
agricultural productivity. Capacity building should, 
therefore be directed towards:  
 
• Country officials involved in negotiations in trade and 
agriculture fora, so they can analyse their needs and 
strengthen their position to defend their interests with 
respect to food security and poverty reduction. 
Availability of such personnel provides capacity for 
technical analysis, critical review of information, 
consultations and peer review of proposal 
applications for donor support or loans, and review of 
implications regarding materials protected by IPR. 
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• End users (farmers), so they may know of the 
technologies available to them, and can make 
informed decisions. 
• Scientists or technical people, so they may undertake 
the development and/or transfer of technology. 
• The public, so that they are correctly informed when 
making their own decisions. 
 
Capacity in biotechnology among African NARS differs. 
For example, FAO (2001b) separates the NARS into 
three categories, namely: 
 
• Group 1 (‘very strong’)—those NARS that have a 
strong capacity in molecular biology, including the 
capacity to develop new tools for their own specific 
needs (e.g. Rep. of South Africa and Egypt). This 
group invests, on average, 5% to 10% of their 
research expenditures on biotechnology. 
• Group 2 (‘medium to strong’)—has considerable 
capacity in applied plant breeding research, and the 
capacity to apply molecular tools (markers and 
transformation protocols), but is dependent on tools 
being developed elsewhere (e.g. many African 
countries, including Zimbabwe, Kenya and Uganda). 
• Group 3 (‘fragile or weak’)—weak capacity in plant 
breeding and virtually no capacity in molecular 
biology (e.g. Zambia and Mozambique). 
 
Links for capacity building with institutions in developed 
countries should be used to transfer (when feasible) 
technology that is available so that this can be efficiently 
used in African research centres. The links should also 
be used to build an essential core of human capacity 
conversant in the area of biotechnology to represent 
different areas and needs.  
Several universities in most countries offer training at 
BSc, MSc and PhD levels in biotechnology and related 
areas. Universities in the Republic of South Africa, such 
as the University of Cape Town, are among the centres 
of excellence in biotechnology, generating GM crops for 
disease resistance and other valuable traits relevant to 
African farmers. The new model for developing PhD 
graduates in Africa at the University of Natal and 
sponsored by the Rockefeller Foundation aims to train 50 
students in plant breeding, at 5 cohorts of 10 PhD 
students per year. The Rockefeller, Ford and MacArthur 
Foundations, and the Carnegie Corporation of New York 
led an initiative on ‘Partnership for Strengthening African 
Universities’. The foundations agreed to a 10-year time 
span, and to spend US$100 million over the first 5 years 
to support universities pursuing reforms in Uganda, 
Tanzania, Mozambique, South Africa (Rep.), Ghana and 
Nigeria. During the first 2 years (2000 and 2001), the four 
foundations together contributed about $62.3 million to 
higher education in these African countries. 
Numerous institutions and organizations offer training 
to developing country nationals. For example, the  U.S.— 
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Egypt Science Technology Joint Board, which supports 
work by U.S. and Egyptian scientists on agricultural 
biotechnology, has been funding about 40 collaborative 
biotechnology projects since 1995. For IITA’s 
Biotechnology Unit, training African scientists is a major 
activity. Training is also offered by BIO-EARN, which 
goes by the long name of “East African Regional 
Programme and Research Network for Biotechnology, 
Biosafety and Biotechnology Policy Development”. Its 
programmes include:  
 
• Short courses (1 or 2 weeks) at the African Centre for 
Technology Studies (ACTS). The courses are 
designed to strengthen the capacities of a core group 
of people from the BIO-EARN countries to analyse, 
formulate and implement biotechnology policies. 
• International training programmes for graduate 
students and visiting scientists. 
• Regional workshops to assist countries in the region 
to gain enough knowledge and confidence to make 
regulatory decisions. 
• Training courses for policy makers from East Africa 
(organized by ACTS). 
• Training in biosafety assessment and field 
evaluations of transgenic crops, including ‘hands-on’ 
training of members of national biosafety committees. 
• Internships for researchers, students and policy 
makers from the region at selected institutions in 
Africa and overseas. 
• Training on risk assessment and other scientific and 
technical expertise. 
• Regional workshops to stimulate awareness of policy 
issues related to biotechnology among policy makers, 
practitioners and the public. 
• Graduate studies. Since its inception in 1999, BIO-
EARN has trained 3 PhD students in ecological risk 
assessment of GMOs and 6 MSc students in various 
fields of GMOs (Magoya, 1999). 
 
To students from developing countries, UNESCO 
actively provides fellowships and courses through its 
Microbial Resources Centres (MIRCENs) and 
Biotechnology Education and Training Centers 
(BETCENs). The International Atomic Energy Agency 
(IAEA) and the African Regional Co-operative Agreement 
(AFRA) also support regional training initiatives in Africa. 
Capacity in gene discovery needs to be built up. Africa 
has an abundance of untapped, indigenous knowledge 
and genetic wealth. Here, the CGIAR centres can play a 
major role by forming strong research partnerships to be 
led by African national programmes. The key to 
successful capacity building is following up and 
effectively deploying the trained manpower. Success 
should be measured, not in the number of researchers 
trained in a new technology at a given time, but in terms 
of what happens after the trained researchers return to 
work in their respective home countries. Do they have the  
 
 
 
 
infrastructure, facilities and resources to apply some of 
the new tools and methods they had acquired? Capacity 
building courses or workshops must be followed up by 
constructing the necessary facilities and acquiring funds 
from donors to conduct biotechnology that will benefit 
African farmers. 
 
 
Partnerships and linkages  
 
Biotechnology ‘coalitions’ should be promoted at local, 
national, regional and international levels (Kameri-Mbote 
et al., 2001). For such partnerships to succeed, two 
aspects must be recognized: (1) that needs vary from 
country to country and should, therefore, be dealt with on 
a country basis, taking into account the specific problems 
of their agricultural sectors; and (2) that similar 
agroecological zones exist, thus facilitating and 
accelerating the transfer of technologies among countries 
and regions. Partnerships should also be used:  
 
• As platforms to launch collaborative work among 
participating countries and/or institutions 
• To increase the capacity of African countries in 
specific policy areas, including IPR 
• To increase African policy makers’ awareness of 
important policy issues in agricultural biotechnology. 
 
Through concerted efforts, creation of electronic 
distribution lists for disseminating information on policy 
and regulatory issues of interest can be established to 
benefit member countries. Capacity building through 
training courses for national officials on specific policy 
issues can be fostered at a regional level and such fora 
can be used to develop specific project proposals to 
address identified gaps and needs of participating 
countries. 
 
Partnerships and networks. Several partnerships and 
networking programmes have been set up at a regional 
level in Africa. They are beginning to create capacities 
and shape the direction of the development and use of 
biotechnology. These programmes include: 
 
• Scientific and technical training courses such as 
those run by BIO-EARN (Mugoya, 2003) 
• Agricultural research and development programmes 
such as those of the African Agency of Biotechnology 
(AAB) and the Association for Strengthening 
Agricultural Research in Eastern and Central Africa 
(ASARECA) biotechnology initiative. 
• Regional biosafety approaches such as that of the 
Eastern and Central African Biosafety Focal Point. 
• Awareness creation networks on biotechnology, 
which include the African Biotechnology Stakeholders 
Forum (ABSF) and AfricaBio (the Biotechnology 
Association for Food, Feed and Fibre) (Wafula, 2001).  
 
 
 
 
The African Agency of Biotechnology (AAB) began in 
1997 as an instrument of African scientists, bringing 
together 16 African member states: Algeria, Burkina Faso, 
Burundi, Cameroon, Côte d’Ivoire, Egypt, Ethiopia, Gabon, 
Ghana, Kenya, Mauritius, Morocco, Nigeria, Senegal, 
Tunisia and Zimbabwe. Its mission, focusing on biosafety 
and bio-policy, aims to: 
 
• Reinforce the national capacities of member states in 
biotechnology training, research, equipment and 
infrastructures. 
• Coordinate and promote cooperative research 
programmes in areas of priority biotechnology 
applications. 
• Enhance dissemination of scientific and technical 
information at regional and sub-regional levels. 
• Encourage the production, distribution and 
commercialization of biotechnology products for 
sustainable development in Africa. 
• Develop and harmonize regulations pertaining to bio-
ethics, and intellectual property and patent rights. 
 
The ASARECA Biotechnology Program.  ASARECA is a 
sub-regional organization for the national agricultural 
research systems (NARS) of 10 African member countries: 
Burundi, Democratic Republic of  Congo,  Eritrea,  Ethiopia, 
Kenya, Madagascar, Rwanda, Sudan, Tanzania and 
Uganda. The association began as an initiative to establish 
a biotechnology and biosafety programme for its members.   
 
The Southern African Regional Biosafety Program 
(SARB), sponsored by USAID and established in 
September 2000, aims to build biosafety capacity to 
permit the safe and responsible introduction of GMOs 
and their products into the region. The programme 
focuses on seven countries that are most likely to make 
decisions on GMOs in the near future: Malawi, Mauritius, 
Mozambique, Namibia, South Africa (Rep.), Zambia and 
Zimbabwe. In addition, SARB conducts activities for all 
countries in the region. The Agricultural Research 
Council (ARC) of South Africa (Rep.) coordinates the 
programme.  
 
The African Agricultural Technology Foundation 
(AATF) is a new initiative that was launched in 2002 with 
funds from the Rockefeller Foundation and USAID. Its 
unique public-private partnership is designed to resolve 
many of the barriers that have prevented smallholder 
farmers in sub-Saharan Africa from gaining access to 
existing agricultural technologies, materials and know-
how that would help relieve food insecurity and poverty. 
The Foundation also aims to help other public-private 
partnerships to also provide smallholders with access to 
improved agricultural technologies (AATF, 2002).  
 
Linking with advanced research institutes. To 
accelerate  capacity  building  in   biotechnology,   African  
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NARS, out of necessity, must forge collaborative links 
with their counterparts in developed countries, 
international organizations and/or other developing 
countries with advanced technologies. Alliances can be 
formed around joint biotechnology R&D projects, with 
emphasis on scientific and technical aspects of risk 
assessment and management.  
 
The Kenya Agricultural Research Institute (KARI), for 
example:  
 
• Collaborates with the John Innes Centre in UK and 
CIMMYT to study maize streak virus resistance. The 
collaboration is funded by the Rockefeller Foundation 
and the Dutch Directorate-General for International 
Co-operation (DGIS). Five scientists have been 
trained in marker-assisted selection (MAS) 
technologies. 
• Has, in response to its training requirements in gene 
construction and crop transformation, formed links 
with Monsanto Company and U.S. universities such 
as Michigan State, Missouri and Texas A&M. 
Collaborative programmes on sweet potato and pest-
resistant maize were set up with funding from 
USAID’s Agricultural Biosafety Support Project 
(ABSP) and the Kenyan Government. Three students 
were trained in crop genetic engineering and 
biosafety development. 
• Has trained as many as 10 of its animal-health 
scientists in recombinant DNA techniques for animal 
disease diagnostics. Their training was carried out 
through an international programme on animal health 
research in collaboration with U.S., UK and Kenyan 
research institutions and universities and with support 
from USAID, DGIS and Department for International 
Developments (DFID). 
 
The CGIAR plays a role in raising awareness and 
capacity building in issues of biosafety, risk assessment 
and patents. It also provides links between advanced 
research institutes (ARIs) and NARS. The CGIAR sister 
centres IITA, International Livestock Research Institute 
(ILRI, Ethiopia and Kenya), ICRAF (Kenya) and West 
Africa Rice Development Association (WARDA, Côte 
d’Ivoire) have their headquarters in Africa. Other regional 
programmes in various parts of Africa are being 
conducted by other CGIAR centres: CIAT (Colombia), 
International Potato Center (CIP, Peru), CIMMYT 
(Mexico), International Center for Agricultural Research in 
the Dry Areas (ICARDA, Syria) and International Crops 
Research Institute for the Semi-Arid Tropics (ICRISAT, 
India). CIAT has recently strengthened its African 
programme by acquiring the Tropical Soil Biology and 
Fertility Programme (TSBF, Kenya) and creating the 
TSBF Institute within CIAT. 
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THE WAY FORWARD 
 
Although enough reasons exist to believe that 
biotechnology will help find solutions to medical, 
agricultural and environmental problems, the ethical, 
environmental, socio-economic and food safety issues 
that underlie the public’s concerns must be addressed 
effectively and responsibly. Public awareness remains 
the key to narrowing the gap between the public’s 
understanding of basic biotechnologies and the rapidly 
advancing science. 
To find a common ground for the use of technologies 
that will benefit humanity, groups such as 
environmentalists, farmers, consumers, the media and 
religious leaders must be included. Some GM crops 
provide environmental benefits and, thus, are compatible 
with the agendas of groups concerned about 
environmental pollution through heavy pesticide use, or 
the use of GM microbes for bioremediation. Other 
benefits include prolonged shelf life of perishable fruits 
and vegetables (thus reducing post-harvest yield losses), 
and resistance to fungal, bacterial and viral diseases 
when the plant gene pool has inadequate sources of 
resistance.  
Strong opponents of biotechnology need to realize that 
the technology is here to stay and, thus, must focus their 
opposition on those applications whose risks truly 
outweigh the sought-after benefits. No technology is risk-
free. On the other hand, strong proponents of 
biotechnology should not dismiss the concerns raised by 
opponents. Who can really forecast with certainty the 
long-term consequences of a potpourri of genes from 
animals, bacteria, viruses or humans in a plant genome? 
Africa still has a long way to go if it is to fully exploit its 
crop production capacity by using available conventional 
methods at the levels achieved in other continents. Even 
so, where genetic engineering is the best or only way to 
achieve a certain agricultural benefit that will make a 
difference in peoples’ lives to significantly outweigh the 
perceived risks, then Africa should use this technology. 
Many biotechnology products are being developed in 
various countries for different uses. These include 
modified plants for food, animal feed, medical care and 
bioremediation. Africans themselves need to examine 
and balance the potential risks of the technologies 
against the confirmed or potential benefits. International 
agricultural research centres should play an active role in 
working together with African scientists and policy 
makers to responsibly deploy those technologies that will 
benefit African farmers and consumers, and develop 
national biotechnology policies. Multinationals and other 
research institutions should fully recognize the valuable 
contributions and free donations made by African farmers 
who conserved priceless genetic resources through thick 
and thin. To return the value of these contributions, such 
entities should make every effort to ensure that at least 
some of their agricultural technologies  and  products  are  
 
 
 
 
available to these poor farmers free of charge. Private 
commercial companies should realize that investing in 
the future of poor farmers and giving them a helping hand 
out of subsistence farming is not only good public 
relations strategy, but will also eventually create new 
markets for them.  
To benefit from biotechnology, Africans must be willing 
to take some potential risks to gain substantial immediate 
and future benefits. The bottom line is that they 
themselves must decide on the future of their agriculture, 
using the best available scientific data and, hopefully, 
taking politics out of the equation.  
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